- Country: Russia
- Summary: Supply of Drugs for Medical Use (Lactulose, Potassium Aspartate + Magnesium Aspartate, Clopidogrel, Aminocaproic Acid, Digoxin, Amiodarone, Spironolacto...
- RUT Ref No: 100822059
- Deadline: 15 May 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: RUB 535997.90
- Notice Type: Tender
- Document Ref. No.: 0321200035424000147
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Supply of drugs for medical use (lactulose, potassium aspartate + magnesium aspartate, clopidogrel, aminocaproic acid, digoxin, amiodarone, spironolactone, captopril, ribavirin, valproic acid, torsemide, bisoprolol, citicoline)
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Drugs for Medical Use (Lactulose, Potassium Aspartate + Magnesium Aspartate, Clopidogrel, Aminocaproic Acid, Digoxin, Amiodarone, Spironolacto... - Russia Tender
The STATE BUDGETARY HEALTH INSTITUTION OF THE STAVROPOL REGION "REGIONAL SPECIALIZED CLINICAL INFECTIOUS HOSPITAL, a Government sector organization in Russia, has announced a new tender for Supply of Drugs for Medical Use (Lactulose, Potassium Aspartate + Magnesium Aspartate, Clopidogrel, Aminocaproic Acid, Digoxin, Amiodarone, Spironolacto.... This tender is published on RussiaTenders under RUT Ref No: 100822059 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-05-15.
The estimated tender value is RUB 535997.90, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
